Masaki N
Dept. of Radiology, Osaka Univ. Med. School.
Gan No Rinsho. 1988 Apr;34(5):675-83.
Radiation therapy has curative potential for patients with stage I-II disease, and five-year relapse-free survival rate in excess of 80% can be expected. Despite an advantage of chemotherapy combined with radiation therapy in improving relapse-free survival, no significant advantage has yet been demonstrated in allover survival. Patients with stage IIIA1 may also be treated radiation therapy alone with results of five-year survival rate of 53-60%. However, patients with stage IIIA2 should be treated with chemotherapy with or without radiation therapy combined.
放射治疗对I-II期疾病患者具有治愈潜力，预计五年无复发生存率超过80%。尽管化疗联合放射治疗在提高无复发生存率方面具有优势，但在总生存率方面尚未显示出显著优势。IIIA1期患者也可单独接受放射治疗，五年生存率为53%-60%。然而，IIIA2期患者应接受化疗，可联合或不联合放射治疗。
